Terns Pharmaceuticals halts its TERN-601 obesity program due to insufficient efficacy and safety concerns. Click here to read ...

When oral medicines for Chronic Myeloid Leukemia (CML) first became available, they dramatically changed what it meant to ...

WICHITA FALLS, Texas (KAUZ) -Erin Holly said she owes her life to her brother after his selfless decision to donate his stem cells. Holly was just 21 years old and a junior at Midwestern State ...

EMA committee recommends marketing approval for Novartis’ Scemblix to treat adults with newly diagnosed CML: Basel Monday, October 20, 2025, 11:00 Hrs [IST] Novartis announced t ...

About Scemblix ® (asciminib) Scemblix® is the first CML treatment that works by Specifically Targeting the ABL Myristoyl Pocket (referred to as a STAMP inhibitor in scientific literature)11-13. Other ...

Prevention is always better than cure, particularly with potentially life-threatening diseases. But when dealing with an ...

The ACLU of MI announced on Tuesday that after being detained for more than two months, Jose Contreras-Cervantes was released and reunited with his family.

Terns Pharmaceuticals said on Tuesday it will stop developing its experimental obesity drug after data from a mid-stage trial showed modest weight loss and raised safety concerns.

A Michigan man facing possible deportation while dealing with life-threatening leukemia must be released from custody or at ...